Sleep Aids Market to Reach $79,851 Million Globally, by 2023 | Top Key Player Analysis - Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, CareFusion Corporation, Tempur-Pedic Management Inc., Serta International, and Drive Medic

The sleep aids market size accounted for $49,543 million in 2016 and is estimated to reach $79,851 million by 2023, registering a CAGR of 7.0% from 2017 to 2023. North America is the highest contributor in the sleep aids market; however, Asia-Pacific has witnessed the highest growth rate in 2016. The presence of large number of sleep disorder cases and rise in awareness about the adverse effects of sleep disorders on human health are anticipated to attract the patients with high purchasing power and boost the market growth.

Download Sample Report with Detailed COVID-19 Impact Analysis at: https://www.alliedmarketresearch.com/request-sample/1533

Sleep aids in the form of drugs and medical devices are used for the diagnosis and treatment of sleep disorders, such as sleep apnea and sleepwalking. These are expected to improve the quality of sleep for patients with sleep disorders. Sleep disorders could adversely affect human health and cause chronic diseases, such as diabetes and cardiovascular diseases.

Change in lifestyle, stressful working conditions, other issues that interfere with sleep habits, rise in disposable income among the customers, and growth in awareness about the adverse effects of sleep disorder on human health are expected to boost the growth of the sleep aids market. The risk of sleep disorder increases with age and obesity thus, the rise in the geriatric and obese population could increase the prevalence of sleep disorder, which is expected to fuel the market growth. The rise in demand for sleep aids has also lead to an increase in the advancement of technology, which will further open new avenues for market growth. However, the adverse effects of sleep drugs on human health and patent expiration are expected to hamper the market growth.

The mattress & pillows segment was the highest revenue contributor in 2016 and is anticipated to continue this trend during the forecast period. The availability of a variety of products, awareness about the health benefits of quality sleep, and advancement in manufacturing techniques are some of the driving factors for the growth of this segment. Insomnia dominates the sleep aids market and is expected to remain the highest contributor toward the market growth, owing to the presence of a large population base suffering from insomnia.

In 2015, North America accounted for maximum contribution to the total revenue generated, owing to the high prevalence rate of sleep disorders, the presence of high disposable income, and the high adoption rate of technologically advanced products. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, attributable to a rise in disposable income, an increase in government initiatives to modernize healthcare infrastructure and rise in healthcare expenditure.

For Purchase Enquiry at https://www.alliedmarketresearch.com/purchase-enquiry/1533

The key companies profiled in the report include

Koninklijke Philips N.V.
Merck & Co.
Sanofi
eVilbiss Healthcare LLC.
Pfizer Inc.
SleepMed Inc.
Cadwell Laboratories Inc.
Compumedics Limited
Natus Medical Incorporated, and
GlaxoSmithKline plc

Similar Report With Detailed COVID-19 Impact Analysis at:

Medical Spa Market by Services (Body Shaping, Hair Removal, Facial Treatment, Tattoo Removal, Scars & Striae, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2025 : https://www.alliedmarketresearch.com/medical-spa-market

Clinical Trial Management (CTM) Market by Delivery Mode (Web-based CTM, On-premise, and Cloud-based CTM), Product Type (Enterprise-based and Site-based), Component (Software, Hardware, and Services), and End Users (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, and Healthcare Providers): Global Opportunity Analysis and Industry Forecast, 2017-2023 : https://www.alliedmarketresearch.com/clinical-trial-management-market

Electrocardiograph (ECG) Market by Product (Resting ECG, Stress ECG, and Holter Monitors), by Lead Type (Single Lead, 3-6 Lead, and 12-Lead), and by End User (Hospitals & Clinics, Home Settings & Ambulatory Surgical Centers (ASCs), and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023 : https://www.alliedmarketresearch.com/electrocardiograph-ECG-market

Gynecological Cancer Drugs Market by Therapeutic Modality (Chemotherapy, Targeted Therapy, and Hormonal Therapy) and Indication (Cervical Cancer, Uterine Cancer, Ovarian Cancer, and Vaginal & Vulvar Cancer) - Global Opportunity Analysis and Industry Forecast, 2017-2023 : https://www.alliedmarketresearch.com/gynecological-cancers-drugs-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/sleep-aids-market
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About US:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.